About Tevosol
Tevosol is a company based in Edmonton (Canada) founded in 2015 by Jayan Nagendran. Tevosol has raised $1.51 million across 1 funding round. The company has 6 employees as of December 31, 2024. Tevosol operates in a competitive market with competitors including TransMedics, OrganOx, Paragonix Technologies, Bridge to Life and Vascular Perfusion, among others.
- Headquarter Edmonton, Canada
- Employees 6 as on 31 Dec, 2024
- Founders Jayan Nagendran
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.51 M (USD)
in 1 rounds
-
Latest Funding Round
$1.51 M (USD), Seed
Aug 14, 2019
-
Investors
Not available
-
Employee Count
6
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Tevosol
Unlock access to complete
Unlock access to complete
Funding Insights of Tevosol
Tevosol has successfully raised a total of $1.51M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.51 million completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Tevosol
Investment portfolio details for Tevosol
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tevosol
Detailed financials for Tevosol
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tevosol Comparisons
Peer comparison for Tevosol
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tevosol
Tevosol operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransMedics, OrganOx, Paragonix Technologies, Bridge to Life and Vascular Perfusion, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of organ transplantation technology
|
|
| Locked | Locked | Locked |
Warm storage and transport systems for harvested organs are provided.
|
|
| Locked | Locked | Locked |
Organ preservation and transport systems are developed for transplants.
|
|
| Locked | Locked | Locked |
Cold storage solutions for organ transplant preservation are provided.
|
|
| Locked | Locked | Locked |
Developer of a device for organ preservation
|
|
| Locked | Locked | Locked |
Multi-organ support systems for liver, lung, and kidney are provided.
|
Detailed competitors of Tevosol
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tevosol
Complete news archive for Tevosol
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tevosol
Tevosol was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Tevosol is headquartered in Edmonton, Canada. It is registered at Edmonton, Alberta, Canada.
Tevosol is a funded company, having raised a total of $1.51M across 1 funding round to date.
As of Dec 31, 2024, the latest employee count at Tevosol is 6.
Tevosol is a developer of portable warm perfusion devices. The portable perfusion device is used during surgery to enable the surgeons to resuscitate, preserve, and transport deceased donor organs.
Tevosol's top competitors include TransMedics, OrganOx and ADVITOS.